Clinical implications of 10-formyltetrahydrofolate dehydrogenase expression in hormone receptor-positive breast cancer - Poll - MDSpire

Clinical implications of 10-formyltetrahydrofolate dehydrogenase expression in hormone receptor-positive breast cancer

  • By

  • Han Suk Ryu

  • Amira A. Abdellatef

  • Da Sol Kim

  • Ilias P. Nikas

  • Sergey A. Krupenko

  • May 25, 2026

  • 0 min

Share

Original Source(s)

Clinical implications of 10-formyltetrahydrofolate dehydrogenase expression in hormone receptor-positive breast cancer

  • by Han Suk Ryu, Amira A. Abdellatef, Da Sol Kim, Ilias P. Nikas, Sergey A. Krupenko

  • May 25, 2026

Related Content

Diagnostic value of multimodal ultrasound imaging in triple-negative breast cancer

Vitamin D-related genetic variants as predictive biomarkers for breast cancer in Jordanian women

Successful reversal of hepatic visceral crisis in HER2-positive metastatic breast cancer: a case report